Tender For allopathic drugs for the year 2025-27 (addendum items as per corrigendum 2) - inj. liposomal irinotican 43mg/10ml, cap. zanubrutinib 80mg, alcohol based pre-soaked wipes with disinfectant solution 700ml with polypropylene based sheet size 12x12.5 inch ( 5%) with canister (pack of 90 wipes or more) (as per cdc and who recommendations), non-ionoic and atmospheric surfactants, solvents, complex agents, corrosion inhibitors, antifoaming agents, preservatives. (as per cdc and who recommendations) 500 ml bottle, pegylated recombinant human erythropoietin injection (100 mcg/0.3ml), pegylated recombinant human erythropoietin injection (75 mcg/0.3ml), pegylated recombinant human erythropoietin injection (50mcg/0.3ml), pegylated recombinant human erythropoietin injection (30 mcg/0.3ml), levo salbutamol inhalation mdi/dpi 50mcg 100 dose
Tender For corrigendum : supply of drugs under group 15. - budesonide inhalation (mdi) 200 mcg/dose, 200 meter dose, budesonide respirator solution for use in nebulizer 0.5 mg/ml , 2 ml ffs amp, budesonide (a)+ formoterol (b) inhalation (mdi) 200 mcg (a)+ 6 mcg (b), 120 meter dose, cough syrup each 5 ml contains ambroxol 15 mg +terbutaline 1.25 mg +guaiphenesin hcl 50 mg with menthol or without menthol as per ip. , 60 ml bottle with measuring cap., cough syrup each 5 ml contains as per indian pharmacopoeia standard, ammonium chloride ip, diphenhydramine hydrochloride ip, sodium citrate menthol ip, 100 ml bottle with measuring cap, dextromethorphan pediatric cough syrup 15mg/5ml, 100 ml bottle with measuring cap, levosulbutamol syrup 1 mg/5ml. , 100 ml bottle with measuring cap, salbutamol tablet 4 mg, 1x10, salbutamol syrup 2 mg/5 ml , 100 ml bottle with measuring cap, salbutamol inhalation (mdi) 100 mcg/dose, 200 meter dose, theophyline(a) & etophylline (b) injection 50.6mg(a) & 169.4 mg(b), 2ml amp, surfactant 80 mg/ ml , 1.5 ml vial